Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
WOW is all I can say. These two presentations have articulated exactly what we've been saying about the poor leadership, lack of strategy, and criminal behavior. Powerful stuff and makes those BOD supporters look very foolish.
Here you go, in black & white
Common Activist Strategy Our Strategy
Elect themselves to a company’s board
We are NOT nominating ourselves to Peregrine’s Board. We believe the Company’s Board should be composed of high
quality, industry professionals who have records of shareholder value creation and the highest ethical standards. We have
no interest in running Peregrine ourselves
Sell the company for a quick gain
We do NOT want Peregrine to sell its main business (and substantially all of the Company’s assets), Contract Design
and Manufacturing (“CDMO”) subsidiary Avid Bioservices, Inc. (“Avid Bioservices”), for a quick “flip.” In fact, when the
Incumbent Board tried to sell Avid Bioservices in 2017, we argued that it was not in shareholders’ best interests. We
believe that managing Avid Bioservices with a long-term outlook is in the best interests of shareholders
Reduce expenses and investments
We have repeatedly stated that significantly more capital should be invested into Avid Bioservices in the form of both
people and equipment. We believe Peregrine must suspend its unsuccessful clinical development business in order to
allocate the needed amount of capital to Avid Bioservices
Nominate directors with close ties Our nominees are all completely independent from us, have no affiliation with our firms of any kind, and have no current
or prior affiliations with each other apart from Peregrine
Biopharm, could you re-post that list of upcoming catalyst that was part of the daily routine here? It would be great to see how we're doing against each of those.
The effort to take votes away from Ronin will not work. There is no such thing as an "unbalanced white card". This is all meant to confuse people in the hopes the broker non-votes goes to the three criminals on the BOD. Based on past precedence listed below there is ZERO credibility in suggesting we support this current BOD. Ronin gets our vote.
CP, now that we have a full slate of candidates from Ronin the only thing left is to vote. You've been a huge proponent of the current BOD and voting the white card. Thankfully we have some history that we can evaluate things to make the best decision. I've recorded some of them:
"Ronin has sold out" - FALSE, they are now the largest shareholder
"RS is highly unlikely" - FALSE, BOD slammed us for the full 7
"RS is neutral" - FALSE, after 3 RS's the PPS is down 90%
"This BOD doesn't abuse ATM" - FALSE, found guilty by court of law
"Ronin can't nominate more candidates" - FALSE, they just did
"Voting more authorized shares is good" - FALSE, it led to more dilution
White card isn't looking so good after all. We're going with Ronin.
Biopharm, could you re-post that list of upcoming catalyst that was part of the daily routine here? It would be great to see how we're doing against each of those.
Doesn't really matter now since we're no longer pursuing the science. Guess the moniker will change to Microsoft of CDMO now.
Since you've been here for many years BioPharm, you would fall into the camp of dividing your shares by 7 and then again by 5. But by all means, continue with this line of thinking if it makes you feel better.
Isn't today the last day PPHM has to set ASM or Ronin will file a lawsuit?
Great job Wookie, perhaps they should hire you to sell the IP. You certainly couldn't do any worse than the current crew.
Great, I hope whomever buys our IP will find this useful. Probably doesn't matter for a CDMO though.
You missed the statement "Not suitable for clinical trials". Doesn't matter though Biopharm, in case you missed it WE ARE NO LONGER GOING AFTER R&D!!
CP you're operating in la-la land today. My post that has you all riled up was about not investing further into R&D.
Posting it again since I new you would try to twist some nonsense in an attempt to put Ronin in a bad light.